Cornea/External Disease News

Patients with dry eye disease have worse sleep quality and may be at greater risk for unhealthy sleep duration, although a causal relationship between dry eye and sleep disorder has not been established, according to a meta-analysis.

Most eyes with keratoconus or corneal ectasia after laser refractive surgery remained stable 10 years after corneal cross-linking, although eyes with keratoconus appeared to be more stable, according to a study in Eye & Contact Lens.

The prevalence of keratoconus in children appeared higher than previously reported, highlighting the importance of early screening for the condition, according to a study published in Eye & Contact Lens.

OCT imaging captured significantly greater meibomian gland length than traditional meibography, likely due to a longer wavelength that penetrates deeper into the eyelids, according to a study published in Contact Lens and Anterior Eye.

BOSTON — In this Healio Video Perspective from the ASCRS meeting, Eris Jordan, OD, of Aurion Biotech, and Elizabeth Yeu, MD, FACS, discuss corneal endothelial cell therapy.

Provectus Biopharmaceuticals announced an exclusive worldwide license agreement with the University of Miami for the university’s photodynamic antimicrobial therapy to treat bacterial, fungal and parasitic eye infections.

BOSTON — In this Healio Video Perspective from the ASCRS meeting, Eric D. Donnenfeld, MD, discusses his presentation on Lacrifill for the treatment of dry eye disease.

BOSTON — In this Healio Video Perspective from the ASCRS meeting, Brandon D. Ayres, MD, ABO, overviews surgical techniques that offer an alternative to corneal transplantation for the treatment of keratoconus.

BOSTON — In this Healio Video Perspective from Eyecelerator@ASCRS, Nordic Pharma Eye Care U.S. president Philip Gioia and chief commercial officer Jai G. Parekh, MD, MBA, FAAO, discuss the launch of Lacrifill for dry eye disease.

BOSTON — In this Healio Video Perspective from the ASCRS meeting, Michael B. Raizman, MD, ABO, discusses the future of corneal cross-linking.